Clinical Research


Clinical TrialsClinical Research

Clinical Trials

Kansas Institute of Research Focused on Safety and Quality Care to our patients. Our research team is committed to exploring new and innovative treatments to better serve our patients, and our team is constantly looking to start new studies that may impact our patients. The Kansas Institute of Research has  been conducting clinical trial for many years.

 

Our clinical trials are conducted within our office location, allowing our team to work closely and provides great accessibility for monitoring patients and proves the safety and quality of our research and care for our patient.

 

Our goal is to provide the opportunity for patients to participate in new treatments and therapies to improve patient’s function. With our research we can help bring new treatments to more patients and have a greater impact on the medical community. We are committed to growth and interested in expanding our clinical trials for our patients.

If you are interested in participating in one of our clinical trials, please see details for our current research studies below. Please contact our research team at 913-652-6475 if any of these current studies interest you.

 

Current Clinical Trials

 

Acute Treatment of Migraine

Potential patients must meet the following criteria:

-Age 18-75 years

-Migraine onset before age 50, at least a 1-year history of migraine.

-History of 2 to 8 migraine attacks per month typically lasting between 4 and 72 hours.

-Be able to read, understand and complete the study questionnaires and eDiary.

 

Botulinum toxin Injection for the Management of Unilateral Plantar Fasciitis

Potential patients must beet the following criteria:

– Age 18-65 years

– Persistent unilateral heel pain for more than three months.

– Failure of conservative treatment including anti-inflammatory medications, splinting, heel pads, stretching exercises, physical therapy and/or steroid injections.

– If you have received steroid injection in the past for plantar fasciitis, must be a least 3 months since last injection.

 

Treatment with Botulinum Toxin for Upper and Lower Extremity Spasticity due to Stroke or Acquired Brain Injury

Potential patients must meet the following criteria:

– Age of at least 18 years

-At least 4 months after the last botulinum toxin (Botox, Dysport, Xeomin) injection, or have never had treatment with botulinum toxin for spasticity.

– Be able to complete a 10 meter walk test barefoot.

– Be able to read, understand and complete the study questionnaires, participate in therapy assessments, and complete therapy exercises daily.

 

Stem Cell Implantation for Chronic Motor Deficit from Ischemic (Non Hemorrhagic) Stroke

Potential patients must meet the following criteria:

– Age 18-75 years

– Between 6 and 90 months (7.5 years) post-stroke.

– Subjects must have had physical therapy prior to entry.

– Willing to undergo multiple brain MRIs and/or CT scans.

– Willing to undergo surgical implantation of stem cells into the brain.

– Able to undergo all planned neurological assessments, physical therapy assessments, and complete regular therapy exercises.

 

Is clinical trial for you?

Who should consider clinical trials and why?

It is important to test drugs and medical products in the people they are meant to help. It is also important to conduct research in a variety of people because different people may respond differently to treatments. FDA seeks to ensure that people of different ages, races, ethnic groups, and genders are included in clinical trials.

 

Some people participate in clinical trials because they have exhausted standard (approved) treatment options – which either did not work for them, or they were unable to tolerate certain side effects. Clinical trials may provide another option when standard therapy has failed.

 

Other people participate in trials because they want to contribute to the advancement of medical knowledge.

 

For each clinical trial, researchers develop eligibility criteria, such as the age, sex, type and stage of disease, previous treatment history, and other medical conditions. These criteria help to reduce the amount of variation in the study, without threatening the scientific integrity of the trial, by removing medical variations that might complicate analyzing the results.

 

Not everyone who applies for a clinical trial will be accepted. Volunteers may be excluded based on the eligibility criteria and/or the number of participants needed by the researchers to collect enough information to determine the safety and effectiveness of a therapeutic agent.